Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Cash from Operations (2019 - 2020)

Updated

Immuron's Cash from Operations came in at -$3.26 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Cash from Operations (2019 - 2020) Analysis & Trends

Going back to FY2015, Immuron's Cash from Operations data covers 12 fiscal years.

  • The FY2026 figure represents the highest annual Cash from Operations since FY2023.
  • Per Business Quant, earlier fiscal years put Cash from Operations at -$6.14 million in FY2025, -$5.88 million in FY2024, -$2 million in FY2023 and -$992,017 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 8.62 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.44 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.57 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 835.00 Mn
10 Immuron 7.32 Mn -9.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 1, 2020 -3.15 Mn
Aug 30, 2019 -1.80 Mn
API Access

Immuron Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=IMRN&period=max&api_key=YOUR_API_KEY